Synergistic combination kit of A,ß-arteether sulfadoxin and pymethamine for treatment of severe multi-drug resistant cerebral malaria

• 1. 一种青蒿琥酯和蒿甲醚联用治疗恶性疟疾的组合物 [P] . 中国专利： CN108245504A . 2018-07-06
• 2. 蒿甲醚脂质体、红细胞膜包脂质体、靶向肽修饰仿生脂质体及其制备方法和治疗疟疾的应用 [P] . 中国专利： CN113521006A . 2021-10-22
• 3. SYNERGISTIC COMBINATION KIT OF α,ß-ARTEETHER, SULFADOXIN AND PYMETHAMINE FOR TREATMENT OF SEVERE/MULTI-DRUG RESISTANT CEREBRAL MALARIA [P] . 世界知识产权组织专利： WO2006070393A1 . 2006-07-06

  机译： α，β-乙炔，磺胺多辛和嘧啶的协同组合套件治疗重度/多药耐药性脑疟

• 4. SYNERGISTIC COMBINATION KITS OF ALPHA, BETA-ARTEETHER, SULFADOXIN AND PYRIMETHAMINE FOR THE TREATMENT OF SEVERE/MULTI-DRUG RESISTANT CEREBRAL MALARIA [P] . IN2005DN01289A . 2008-02-01

  机译： 阿尔法，β-青蒿素，磺胺多辛和乙胺嘧啶的协同组合药盒用于治疗重度/多药耐药性脑疟疾

• 5. Synergistic combination kit of alpha,beta-arteether, sulfadoxin and pyrimethamine for treatment of severe/multi-drug resistant cerebral malaria [P] . 美国专利： US2006141024A1 . 2006-06-29

  机译： α，β-蒿甲醚，磺胺多辛和乙胺嘧啶的协同组合试剂盒，用于治疗重度/多重耐药性脑疟疾

• 1. Risk Factors of Treatment Outcomes for Multi-drug Resistant Tuberculosis in Shanghai, 2009-2012 [C] . Dengkui Li, Erjia Ge, Xin Shen International conference on geographies of health and living in cities . 2017
• 2. Biomarkers of severe malaria: Complement activation and dysregulated angiogenesis in placental malaria and cerebral malaria [D] . Conroy, Andrea 2011
• 3. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative [O] . Minxian Dai, Brandi Freeman, Fernando P. Bruno, -1
• 4. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative [O] . Dai Minxian, Freeman Brandi, Bruno Fernando P., 2012

• 1. Analysis of Clinical Symptoms Improvement in Treatment of Severe Pneumonia Caused by Multi-drug Resistant Bacterial Infection by Bronchoscopy Alveolar Lavage [J] . Xiang Wang ,Zuozhou Xie ,Jinhong Zhao . 临床护理研究 . 2021,第004期
• 2. Mathematical rules for synergistic,additive,and antagonistic effects of multi-drug combinations and their application in research and development of combinatorial drugs and special medical food combinations [J] . Shoujun Yuan ,Haoyu Chen . 食品科学与人类健康（英文） . 2019,第2期
• 3. Revisiting the Evaluation of the Effectiveness of Artemether-Lumefantrine Combination in the Treatment of Uncomplicated Malaria in Elele, a Malaria Endemic Area in Rivers State Nigeria [J] . L. C. Chukwu ,P. U. Agbasi ,P. C. Unekwe . 生物科学与医学（英文） . 2019,第6期
• 4. Synergistic Anticancer Activity of Topotecan— Cyclin-Dependent Kinase Inhibitor Combinations against Drug-Resistant Small Cell Lung Cancer (SCLC) Cell Lines [J] . Gerhard Hamilton ,Ulrike Olszewski Lukas Klameth ,Ernst Ulsperger . 癌症治疗（英文） . 2013,第8期
• 5. The Synergistic Inhibitory Effect of STI571 in Combination with Arsenic Trioxide （As2O3） on Multidrug-Resistant Leukemic Cells [J] . LiChen JianminWang XiaopingXu LeiGao XinhongFei JingweiLou ZhengxiaHuang . 中国肿瘤临床：英文版 . 2005,第3期
• 6. 重组鸭β-防御素-2对多重耐药性大肠杆菌攻毒雏鸡的治疗效果研究 [C] . Yan Xia ,严霞 ,Han Xiaofeng . 第25届广东省科技进步活动月——畜牧兽医学术与科技创新发展大会 . 2016
• 7. 脑靶向载药纳米胶束治疗胶质瘤和耐药性癫痫的实验研究 [A] . 刘晓英 . 2009